Microbial Metabolism and Disease

Microbiome Metabolic Pathways and Disease provides insight into the interaction of microbial metabolic pathways in the human body and the impact these can have on a variety of diseases. By analyzing these pathways the book seeks to investigate how these metabolic processes can be targeted and manipulated in order to treat various disorders and diseases. Les mer
Vår pris
1715,-

(Paperback) Fri frakt!
Leveringstid: Sendes innen 7 virkedager

Paperback
Legg i
Paperback
Legg i
Vår pris: 1715,-

(Paperback) Fri frakt!
Leveringstid: Sendes innen 7 virkedager

Om boka

Microbiome Metabolic Pathways and Disease provides insight into the interaction of microbial metabolic pathways in the human body and the impact these can have on a variety of diseases. By analyzing these pathways the book seeks to investigate how these metabolic processes can be targeted and manipulated in order to treat various disorders and diseases. Topics covered in the book include microbial shikimate pathways, protein biosynthesis, tryptophan metabolites, microbiome metabolic engineering, fecal microbiota transplantation, and virulence factors. Additionally, a variety of conditions are covered, such as disorders associated with metabolic syndromes, serotonin syndromes, Alzheimer's disease, and Covid-19, providing a detailed overview of how metabolic pathways of microbiome can impact health and disease in the human body.

Fakta

Innholdsfortegnelse

1. Naturally occurring affectors of initial step of protein biosynthesis 2. Physicochemical, biochemical and cell biology properties and byproducts of tryptamine and other "trace" amines 3. Tryptophan metabolites and biogenic amines in physical exercises 4. Tryptamine in inflammation and regulation of gene transcription 5. Genes encoding mammalian, plant and microbial aromatic amino acid decarboxylase 6. Decarboxylases producing tryptamine and other biogenic amines in human microbiome 7. Microbial shikimate pathway in diseases 8. Biogenic amines in fasting, feeding and stress conditions 9. Metabolites of shikimate and tryptophan pathways in Corona virus disease (COVID-19) 10. Virulence factors 11. Relation of human gut Alzheimer's disease associated sequence (ADAS) with shikimate pathway metabolites 12. Benefits of using fecal microbiota transplantation as treatment have been controversial 13. Shikimate pathway enzymes in human microbiome 14. Tryptophan operon in human microbiome and inhibitors of tryptophan operon enzymes 15. Antibodies to tryptamines 16. Cell death in Alzheimer's disease brain and tryptamine-treated cells

Om forfatteren

Dr. Elena Paley is the Founder, President & CEO of Expert Biomed Inc., and Co-founder and Director of Stop Alzheimer's Corp. She completed her PhD in Biology at The Engelhardt Institute of Molecular Biology, at the Russian Academy of Sciences, Moscow, Russia and later conducted postdoctoral research at the University of Miami School of Medicine, Miami, FL. Dr. Paley's research focuses on protein biosynthesis interference in disease, with emphasis on cancer and neurodegenerative disease. During her career she has taught and held professorships at Northwestern University Feinberg School of Medicine and Nova Southeastern University in Ft. Lauderdale, FL, among other schools. Dr. Paley is on the review board of various scientific journals, including the Journal of Alzheimer's Disease and Current Alzheimer Research.